Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients

Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.

The supportive care of patients receiving antineoplastic treatment has dramatically improved over the past few years and development of effective measures to prevent nausea and vomiting after chemotherapy serves as one of the most important examples of this progress. A patient who starts cancer treatment with chemotherapy lists chemotherapy-induced nausea and vomiting as among their greatest fe...

The effect of Vitamin B6 on chemotherapy induced nausea and vomiting in pediatric cancer

Background: Nausea and vomiting are the common side-effects of chemotherapy in children with malignancy. In this study, the effectiveness of vitamin B6 in reducing the chemo-induced nausea and vomiting (CINV) in children was tested. Material and methods: A triple-blind clinical trials was performed on 100 children with malignancy referring to the pediatric clinic of Amir Kabir Hospital, Arak, ...

Chemotherapy-induced nausea and vomiting: strategies for prevention and treatment.

Status of Cancer Chemotherapy, and the Prevention and Mechanism of Chemotherapy- Induced Nausea and Vomiting

Malignant neoplasms remain a leading cause of death worldwide (Siegel et al., 2014). At the beginning of this century, comprehensive treatment for malignant neoplasm had progressed considerably with advances in moleculartargeted therapy, immunotherapy and gene therapy. However, chemotherapy is still the primary treatment. Chemotherapy-induced nausea and vomiting (CINV) is the most common and in...

Chemotherapy-induced nausea and vomiting.

younger patient age, platinumor anthracyclinebased chemotherapy, low alcohol consumption, earlier cycles of chemotherapy, previous history of morning sickness, and prior emetic episodes after chemotherapy. The acute and delayed scoring systems both had good predictive accuracy when applied to the external validation sample (acute— auroc: 0.69; 95% confidence interval: 0.59 to 0.79; delayed—auro...